{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:17:18Z","timestamp":1782706638807,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T00:00:00Z","timestamp":1328572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10689-012-9509-7","type":"journal-article","created":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T14:32:17Z","timestamp":1328538737000},"page":"307-311","source":"Crossref","is-referenced-by-count":19,"title":["Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients"],"prefix":"10.1007","volume":"11","author":[{"given":"Muhammad U.","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Gull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Asghar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Hamann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,7]]},"reference":[{"key":"9509_CR1","first-page":"77","volume":"5","author":"Y Bhurgri","year":"2004","unstructured":"Bhurgri Y (2004) Karachi Cancer Registry Data\u2013implications for the National Cancer Control Program of Pakistan. Asian Pac J Cancer Prev 5:77\u201382","journal-title":"Asian Pac J Cancer Prev"},{"key":"9509_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2407-10-191","volume":"10","author":"M Kakarala","year":"2010","unstructured":"Kakarala M, Rozek L, Cote M, Liyanage S, Brenner DE (2010) Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the US\u2013a SEER analysis. BMC Cancer 10:191","journal-title":"BMC Cancer"},{"key":"9509_CR3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10549-011-1362-0","volume":"128","author":"MS Moran","year":"2011","unstructured":"Moran MS, Gonsalves L, Goss DM, Ma S (2011) Breast cancers in US residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival. Breast Cancer Res Treat 128:543\u2013551","journal-title":"Breast Cancer Res Treat"},{"key":"9509_CR4","first-page":"5358","volume":"48","author":"FP Li","year":"1988","unstructured":"Li FP, Fraumeni JF Jr, Mulvihill JJ et al (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358\u20135362","journal-title":"Cancer Res"},{"key":"9509_CR5","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin D, Li FP, Strong LC et al (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233\u20131238","journal-title":"Science"},{"key":"9509_CR6","first-page":"1298","volume":"54","author":"JM Birch","year":"1994","unstructured":"Birch JM, Hartley AL, Tricker KJ et al (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54:1298\u20131304","journal-title":"Cancer Res"},{"key":"9509_CR7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/jmg.39.12.941","volume":"39","author":"DG Evans","year":"2002","unstructured":"Evans DG, Birch JM, Thorneycroft M, McGown G, Lalloo F, Varley JM (2002) Low rate of TP53 germline mutations in breast cancer\/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome. J Med Genet 39:941\u2013944","journal-title":"J Med Genet"},{"key":"9509_CR8","first-page":"608","volume":"56","author":"T Frebourg","year":"1995","unstructured":"Frebourg T, Barbier N, Yan YX et al (1995) Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 56:608\u2013615","journal-title":"Am J Hum Genet"},{"key":"9509_CR9","first-page":"6643","volume":"63","author":"M Olivier","year":"2003","unstructured":"Olivier M, Goldgar DE, Sodha N et al (2003) Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 63:6643\u20136650","journal-title":"Cancer Res"},{"key":"9509_CR10","first-page":"3245","volume":"57","author":"JM Varley","year":"1997","unstructured":"Varley JM, McGown G, Thorncroft M et al (1997) Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 57:3245\u20133252","journal-title":"Cancer Res"},{"key":"9509_CR11","first-page":"57","volume":"18","author":"RA Eeles","year":"1993","unstructured":"Eeles RA, Bartkova J, Lane DP, Bartek J (1993) The role of TP53 in breast cancer development. Cancer Surv 18:57\u201375","journal-title":"Cancer Surv"},{"key":"9509_CR12","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1054\/bjoc.2000.1167","volume":"82","author":"A Chompret","year":"2000","unstructured":"Chompret A, Brugieres L, Ronsin M et al (2000) P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer 82:1932\u20131937","journal-title":"Br J Cancer"},{"key":"9509_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jmg.38.1.43","volume":"38","author":"A Chompret","year":"2001","unstructured":"Chompret A, Abel A, Stoppa-Lyonnet D et al (2001) Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 38:43\u201347","journal-title":"J Med Genet"},{"key":"9509_CR14","first-page":"171","volume":"18","author":"BC Le","year":"1994","unstructured":"Le BC, Bonaiti-Pellie C (1994) A method for estimating cancer risk in p53 mutation carriers. Cancer Detect Prev 18:171\u2013178","journal-title":"Cancer Detect Prev"},{"key":"9509_CR15","first-page":"3234","volume":"52","author":"AL Borresen","year":"1992","unstructured":"Borresen AL, Andersen TI, Garber J et al (1992) Screening for germ line TP53 mutations in breast cancer patients. Cancer Res 52:3234\u20133236","journal-title":"Cancer Res"},{"key":"9509_CR16","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","volume":"27","author":"KD Gonzalez","year":"2009","unstructured":"Gonzalez KD, Noltner KA, Buzin CH et al (2009) Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 27:1250\u20131256","journal-title":"J Clin Oncol"},{"key":"9509_CR17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(03)12856-5","volume":"361","author":"F Lalloo","year":"2003","unstructured":"Lalloo F, Varley J, Ellis D et al (2003) Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet 361:1101\u20131102","journal-title":"Lancet"},{"key":"9509_CR18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ejca.2005.11.032","volume":"42","author":"F Lalloo","year":"2006","unstructured":"Lalloo F, Varley J, Moran A et al (2006) BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Eur J Cancer 42:1143\u20131150","journal-title":"Eur J Cancer"},{"key":"9509_CR19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/bjc.1991.44","volume":"63","author":"J Prosser","year":"1991","unstructured":"Prosser J, Elder PA, Condie A, MacFadyen I, Steel CM, Evans HJ (1991) Mutations in p53 do not account for heritable breast cancer: a study in five affected families. Br J Cancer 63:181\u2013184","journal-title":"Br J Cancer"},{"key":"9509_CR20","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","volume":"295","author":"T Walsh","year":"2006","unstructured":"Walsh T, Casadei S, Coats KH et al (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379\u20131388","journal-title":"JAMA"},{"key":"9509_CR21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10549-007-9608-6","volume":"108","author":"SL Arcand","year":"2008","unstructured":"Arcand SL, Maugard CM, Ghadirian P et al (2008) Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families. Breast Cancer Res Treat 108:399\u2013408","journal-title":"Breast Cancer Res Treat"},{"key":"9509_CR22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10689-009-9287-z","volume":"8","author":"OM Ginsburg","year":"2009","unstructured":"Ginsburg OM, Akbari MR, Aziz Z et al (2009) The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30. Fam Cancer 8:563\u2013567","journal-title":"Fam Cancer"},{"key":"9509_CR23","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1158\/0008-5472.CAN-09-0851","volume":"70","author":"J Mouchawar","year":"2010","unstructured":"Mouchawar J, Korch C, Byers T et al (2010) Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian breast cancer family study. Cancer Res 70:4795\u20134800","journal-title":"Cancer Res"},{"key":"9509_CR24","first-page":"2984","volume":"52","author":"D Sidransky","year":"1992","unstructured":"Sidransky D, Tokino T, Helzlsouer K et al (1992) Inherited p53 gene mutations in breast cancer. Cancer Res 52:2984\u20132986","journal-title":"Cancer Res"},{"key":"9509_CR25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10549-009-0349-6","volume":"119","author":"AY Cao","year":"2010","unstructured":"Cao AY, Jin W, Shi PC, Di GH, Shen ZZ, Shao ZM (2010) Identification and characterization of two novel germ line p53 mutations in the non-LFS\/non-LFL breast cancer families in Chinese population. Breast Cancer Res Treat 119:295\u2013303","journal-title":"Breast Cancer Res Treat"},{"key":"9509_CR26","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1002\/ijc.22269","volume":"119","author":"MU Rashid","year":"2006","unstructured":"Rashid MU, Zaidi A, Torres D et al (2006) Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer 119:2832\u20132839","journal-title":"Int J Cancer"},{"key":"9509_CR27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-022X(00)00153-6","volume":"47","author":"E Gross","year":"2001","unstructured":"Gross E, Kiechle M, Arnold N (2001) Mutation analysis of p53 in ovarian tumors by DHPLC. J Biochem Biophys Methods 47:73\u201381","journal-title":"J Biochem Biophys Methods"},{"key":"9509_CR28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1349-7006.2007.00686.x","volume":"99","author":"T Shimmyo","year":"2008","unstructured":"Shimmyo T, Okada A, Hashimoto T et al (2008) Etiologic value of p53 mutation spectra and differences with histology in lung cancers. Cancer Sci 99:287\u2013295","journal-title":"Cancer Sci"},{"key":"9509_CR29","first-page":"105","volume":"120","author":"F Riedel","year":"2000","unstructured":"Riedel F, Gotte K, Schwalb J, Schafer C, Hormann K (2000) Vascular endothelial growth factor expression correlates with p53 mutation and angiogenesis in squamous cell carcinoma of the head and neck. Acta Otolaryngol 120:105\u2013111","journal-title":"Acta Otolaryngol"},{"key":"9509_CR30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/gcc.2870030411","volume":"3","author":"ES Han","year":"1991","unstructured":"Han ES, Moyer MP, Naylor S, Sakaguchi AY (1991) Mutation in the TP53 gene in colorectal carcinoma detected by polymerase chain reaction. Genes Chromosomes Cancer 3:313\u2013317","journal-title":"Genes Chromosomes Cancer"},{"key":"9509_CR31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ijc.21002","volume":"116","author":"MM Mir","year":"2005","unstructured":"Mir MM, Dar NA, Gochhait S, Zargar SA, Ahangar AG, Bamezai RN (2005) p53 mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): a high-incidence area. Int J Cancer 116:62\u201368","journal-title":"Int J Cancer"},{"key":"9509_CR32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0964-1955(96)00030-9","volume":"32B","author":"A Kropveld","year":"1996","unstructured":"Kropveld A, van Mansfeld AD, Nabben N, Hordijk GJ, Slootweg PJ (1996) Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients. Eur J Cancer B Oral Oncol 32B:388\u2013393","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"9509_CR33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ijc.20712","volume":"114","author":"O Yamanoshita","year":"2005","unstructured":"Yamanoshita O, Kubota T, Hou J et al (2005) DHPLC is superior to SSCP in screening p53 mutations in esophageal cancer tissues. Int J Cancer 114:74\u201379","journal-title":"Int J Cancer"},{"key":"9509_CR34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/jcp.21428","volume":"216","author":"M Mahdavinia","year":"2008","unstructured":"Mahdavinia M, Bishehsari F, Verginelli F et al (2008) P53 mutations in colorectal cancer from northern Iran: relationships with site of tumor origin, microsatellite instability and K-ras mutations. J Cell Physiol 216:543\u2013550","journal-title":"J Cell Physiol"},{"key":"9509_CR35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrg3051","volume":"12","author":"ZE Sauna","year":"2011","unstructured":"Sauna ZE, Kimchi-Sarfaty C (2011) Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 12:683\u2013691","journal-title":"Nat Rev Genet"},{"key":"9509_CR36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jmg.2008.057570","volume":"45","author":"G Bougeard","year":"2008","unstructured":"Bougeard G, Sesboue R, Baert-Desurmont S et al (2008) Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. J Med Genet 45:535\u2013538","journal-title":"J Med Genet"},{"key":"9509_CR37","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1078-0432.CCR-05-1029","volume":"12","author":"M Olivier","year":"2006","unstructured":"Olivier M, Langerod A, Carrieri P et al (2006) The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin Cancer Res 12:1157\u20131167","journal-title":"Clin Cancer Res"},{"key":"9509_CR38","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/bcr1675","volume":"9","author":"A Langerod","year":"2007","unstructured":"Langerod A, Zhao H, Borgan O et al (2007) TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer. Breast Cancer Res 9:R30","journal-title":"Breast Cancer Res"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-012-9509-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-012-9509-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-012-9509-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:46:07Z","timestamp":1559252767000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-012-9509-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,7]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9509"],"URL":"https:\/\/doi.org\/10.1007\/s10689-012-9509-7","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,7]]}}}